Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling

Responses to alpha interferon (IFN-α)-based treatment are dependent on both host and viral factors and vary markedly among patients infected with different hepatitis C virus (HCV) genotypes (GTs). Patients infected with GT3 viruses consistently respond better to IFN treatment than do patients infect...

Full description

Saved in:
Bibliographic Details
Main Authors: Kumthip K., Chusri P., Jilg N., Zhao L., Fusco D.N., Zhao H., Goto K., Cheng D., Schaefer E.A., Zhang L., Pantip C., Thongsawat S., O'Brien A., Peng L.F., Maneekarn N., Chung R.T., Lin W.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-84865086668&partnerID=40&md5=9a98250d2f7e7c7f45bc0649c7a03495
http://www.ncbi.nlm.nih.gov/pubmed/22674974
http://cmuir.cmu.ac.th/handle/6653943832/3891
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English
id th-cmuir.6653943832-3891
record_format dspace
spelling th-cmuir.6653943832-38912014-08-30T02:35:26Z Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling Kumthip K. Chusri P. Jilg N. Zhao L. Fusco D.N. Zhao H. Goto K. Cheng D. Schaefer E.A. Zhang L. Pantip C. Thongsawat S. O'Brien A. Peng L.F. Maneekarn N. Chung R.T. Lin W. Responses to alpha interferon (IFN-α)-based treatment are dependent on both host and viral factors and vary markedly among patients infected with different hepatitis C virus (HCV) genotypes (GTs). Patients infected with GT3 viruses consistently respond better to IFN treatment than do patients infected with GT1 viruses. The mechanisms underlying this difference are not well understood. In this study, we sought to determine the effects of HCV NS5A proteins from different genotypes on IFN signaling. We found that the overexpression of either GT1 or GT3 NS5A proteins significantly inhibited IFN-induced IFN-stimulated response element (ISRE) signaling, phosphorylated STAT1 (P-STAT1) levels, and IFN-stimulated gene (ISG) expression compared to controls. GT1 NS5A protein expression exhibited stronger inhibitory effects on IFN signaling than did GT3 NS5A protein expression. Furthermore, GT1 NS5A bound to STAT1 with a higher affinity than did GT3 NS5A. Domain mapping revealed that the C-terminal region of NS5A conferred these inhibitory effects on IFN signaling. The overexpression of HCV NS5A increased HCV replication levels in JFH1-infected cells through the further reduction of levels of P-STAT1, ISRE signaling, and downstream ISG responses. We demonstrated that the overexpression of GT1 NS5A proteins resulted in less IFN responsiveness than did the expression of GT3 NS5A proteins through stronger binding to STAT1. We confirmed that GT1 NS5A proteins exerted stronger IFN signaling inhibition than did GT3 NS5A proteins in an infectious recombinant JFH1 virus. The potent antiviral NS5A inhibitor BMS-790052 did not block NS5A-mediated IFN signaling suppression in an overexpression model, suggesting that NS5A's contributions to replication are independent of its subversive action on IFN. We propose a model in which the binding of the C-terminal region of NS5A to STAT1 leads to decreased levels of P-STAT1, ISRE signaling, and ISG transcription and, ultimately, to preferential GT1 resistance to IFN treatment. © 2012, American Society for Microbiology. 2014-08-30T02:35:26Z 2014-08-30T02:35:26Z 2012 Article 0022538X 10.1128/JVI.00533-12 22674974 JOVIA http://www.scopus.com/inward/record.url?eid=2-s2.0-84865086668&partnerID=40&md5=9a98250d2f7e7c7f45bc0649c7a03495 http://www.ncbi.nlm.nih.gov/pubmed/22674974 http://cmuir.cmu.ac.th/handle/6653943832/3891 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description Responses to alpha interferon (IFN-α)-based treatment are dependent on both host and viral factors and vary markedly among patients infected with different hepatitis C virus (HCV) genotypes (GTs). Patients infected with GT3 viruses consistently respond better to IFN treatment than do patients infected with GT1 viruses. The mechanisms underlying this difference are not well understood. In this study, we sought to determine the effects of HCV NS5A proteins from different genotypes on IFN signaling. We found that the overexpression of either GT1 or GT3 NS5A proteins significantly inhibited IFN-induced IFN-stimulated response element (ISRE) signaling, phosphorylated STAT1 (P-STAT1) levels, and IFN-stimulated gene (ISG) expression compared to controls. GT1 NS5A protein expression exhibited stronger inhibitory effects on IFN signaling than did GT3 NS5A protein expression. Furthermore, GT1 NS5A bound to STAT1 with a higher affinity than did GT3 NS5A. Domain mapping revealed that the C-terminal region of NS5A conferred these inhibitory effects on IFN signaling. The overexpression of HCV NS5A increased HCV replication levels in JFH1-infected cells through the further reduction of levels of P-STAT1, ISRE signaling, and downstream ISG responses. We demonstrated that the overexpression of GT1 NS5A proteins resulted in less IFN responsiveness than did the expression of GT3 NS5A proteins through stronger binding to STAT1. We confirmed that GT1 NS5A proteins exerted stronger IFN signaling inhibition than did GT3 NS5A proteins in an infectious recombinant JFH1 virus. The potent antiviral NS5A inhibitor BMS-790052 did not block NS5A-mediated IFN signaling suppression in an overexpression model, suggesting that NS5A's contributions to replication are independent of its subversive action on IFN. We propose a model in which the binding of the C-terminal region of NS5A to STAT1 leads to decreased levels of P-STAT1, ISRE signaling, and ISG transcription and, ultimately, to preferential GT1 resistance to IFN treatment. © 2012, American Society for Microbiology.
format Article
author Kumthip K.
Chusri P.
Jilg N.
Zhao L.
Fusco D.N.
Zhao H.
Goto K.
Cheng D.
Schaefer E.A.
Zhang L.
Pantip C.
Thongsawat S.
O'Brien A.
Peng L.F.
Maneekarn N.
Chung R.T.
Lin W.
spellingShingle Kumthip K.
Chusri P.
Jilg N.
Zhao L.
Fusco D.N.
Zhao H.
Goto K.
Cheng D.
Schaefer E.A.
Zhang L.
Pantip C.
Thongsawat S.
O'Brien A.
Peng L.F.
Maneekarn N.
Chung R.T.
Lin W.
Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling
author_facet Kumthip K.
Chusri P.
Jilg N.
Zhao L.
Fusco D.N.
Zhao H.
Goto K.
Cheng D.
Schaefer E.A.
Zhang L.
Pantip C.
Thongsawat S.
O'Brien A.
Peng L.F.
Maneekarn N.
Chung R.T.
Lin W.
author_sort Kumthip K.
title Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling
title_short Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling
title_full Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling
title_fullStr Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling
title_full_unstemmed Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling
title_sort hepatitis c virus ns5a disrupts stat1 phosphorylation and suppresses type i interferon signaling
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-84865086668&partnerID=40&md5=9a98250d2f7e7c7f45bc0649c7a03495
http://www.ncbi.nlm.nih.gov/pubmed/22674974
http://cmuir.cmu.ac.th/handle/6653943832/3891
_version_ 1681420134222135296